 |
|
|
| |
poster - Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
|
| |
| |
in the oral talk author said side effects profile was the same as in gen population & affects on VL & CD4, CD8 were safe.
|
| |
|
|
|
|
|
